Pages with the fewest revisions

Jump to: navigation, search

Showing below up to 50 results in range #1 to #50.

View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)

  1. Trastuzumab emtansine (T-DM1)‏‎ (1 revision - redirect page)
  2. Cortisone‏‎ (1 revision)
  3. Tbo-filgrastim (Granix, Neutroval)‏‎ (1 revision - redirect page)
  4. Paroxysmal nocturnal hemoglobinuria (PNH)‏‎ (1 revision - redirect page)
  5. MDS‏‎ (1 revision - redirect page)
  6. Radotinib (IY5511HCL)‏‎ (1 revision - redirect page)
  7. Etoposide (Vepesid, VP-16)‏‎ (1 revision - redirect page)
  8. 5FU‏‎ (1 revision - redirect page)
  9. Ascorbic acid (Vitamin C)‏‎ (1 revision)
  10. Renal cancer‏‎ (1 revision - redirect page)
  11. Unknown primary‏‎ (1 revision - redirect page)
  12. DLBCL‏‎ (1 revision - redirect page)
  13. Duvelisib (IPI-145)‏‎ (1 revision - redirect page)
  14. Doxorubicin liposomal (Doxil)‏‎ (1 revision - redirect page)
  15. Pertuzumab (Omnitarg)‏‎ (1 revision - redirect page)
  16. Selpercatinib (Retevmo)‏‎ (1 revision)
  17. Polycythaemia vera‏‎ (1 revision - redirect page)
  18. Uterine cancer‏‎ (1 revision - redirect page)
  19. Cabozantinib (Cabometyx)‏‎ (1 revision - redirect page)
  20. Enzalutamide (MDV3100)‏‎ (1 revision - redirect page)
  21. PNH‏‎ (1 revision - redirect page)
  22. 5-FU‏‎ (1 revision - redirect page)
  23. Durvalumab (MEDI4736)‏‎ (1 revision - redirect page)
  24. XmAb5574 (MOR00208)‏‎ (1 revision - redirect page)
  25. AG-221‏‎ (1 revision - redirect page)
  26. Afuresertib‏‎ (1 revision - redirect page)
  27. Isatuximab (SAR-650984)‏‎ (1 revision - redirect page)
  28. Autologous HSCT conditioning regimens‏‎ (1 revision - redirect page)
  29. COVID-19 and cancer‏‎ (1 revision - redirect page)
  30. Mepolizumab (Bosatria)‏‎ (1 revision - redirect page)
  31. Dacomitinib (PF-00299804)‏‎ (1 revision - redirect page)
  32. Ripretinib (Qinlock)‏‎ (1 revision)
  33. Acute myelogenous leukemia‏‎ (1 revision - redirect page)
  34. Atezolizumab (MPDL3280A)‏‎ (1 revision - redirect page)
  35. Bosutinib (SKI-606)‏‎ (1 revision - redirect page)
  36. Omacetaxine mepesuccinate (Synribo)‏‎ (1 revision - redirect page)
  37. Chronic lymphocytic leukemia (CLL/SLL)‏‎ (1 revision - redirect page)
  38. Acute lymphocytic leukemia‏‎ (1 revision - redirect page)
  39. Ewing's sarcoma‏‎ (1 revision - redirect page)
  40. 5-fluorouracil‏‎ (1 revision - redirect page)
  41. Selinexor (KPT-330)‏‎ (1 revision - redirect page)
  42. Vocabulary concepts‏‎ (1 revision - redirect page)
  43. Tegafur-uracil (UFT)‏‎ (1 revision - redirect page)
  44. GDC-0941‏‎ (1 revision - redirect page)
  45. Allogeneic HSCT conditioning regimens‏‎ (1 revision - redirect page)
  46. Idarucizumab‏‎ (1 revision - redirect page)
  47. Daratumumab (HuMax-CD38)‏‎ (1 revision - redirect page)
  48. Cemiplimab (REGN2810)‏‎ (1 revision - redirect page)
  49. Aclarubicin (Aclacinomycin)‏‎ (1 revision - redirect page)
  50. HCC‏‎ (1 revision - redirect page)

View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)